Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10363893" target="_blank" >RIV/00216208:11110/17:10363893 - isvavai.cz</a>
Alternative codes found
RIV/00023728:_____/17:N0000023
Result on the web
<a href="http://dx.doi.org/10.1186/s13075-017-1288-y" target="_blank" >http://dx.doi.org/10.1186/s13075-017-1288-y</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1186/s13075-017-1288-y" target="_blank" >10.1186/s13075-017-1288-y</a>
Alternative languages
Result language
angličtina
Original language name
Calgizzarin (S100A11): a novel inflammatory mediator associated with disease activity of rheumatoid arthritis
Original language description
Background: Calgizzarin (S100A11) is a member of the S100 protein family that acts in different tumors by regulating a number of biologic functions. Recent data suggest its association with low-grade inflammation in osteoarthritis (OA). The aim of our study is to compare S100A11 expression in the synovial tissues, synovial fluid and serum of patients with rheumatoid arthritis (RA) and osteoarthritis (OA) and to characterize the potential association between S100A11 and disease activity. Methods: S100A11 protein expression was detected in synovial tissue from patients with RA (n = 6) and patients with OA (n = 6) by immunohistochemistry and immunofluorescence. Serum and synovial fluid S100A11 levels were measured by ELISA in patients with RA (n = 40) and patients with OA (n = 34). Disease activity scores in 28 joints based on C-reactive protein (DAS28-CRP) were used to assess disease activity. Cytokine content in peripheral blood mononuclear cells (PBMCs), synovial fibroblasts (SFs) and synovial fluid was analysed by ELISA, western blotting or cytometric bead array. Conclusions: Our data provide the first evidence of S100A11 up-regulation and its association with inflammation and disease activity in patients with RA.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30226 - Rheumatology
Result continuities
Project
<a href="/en/project/NV15-34065A" target="_blank" >NV15-34065A: Role of S100A11 (calgizzarin) in the pathogenesis of rheumatoid arthritis</a><br>
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Arthritis Research & Therapy
ISSN
1478-6354
e-ISSN
—
Volume of the periodical
19
Issue of the periodical within the volume
April
Country of publishing house
GB - UNITED KINGDOM
Number of pages
10
Pages from-to
—
UT code for WoS article
000401177500003
EID of the result in the Scopus database
2-s2.0-85018293040